Cytokeratin 19 fragment (CY211) Recombinant Rabbit mAb (Alexa Fluor??488 Conjugate) (SDT-197-28)

產(chǎn)品簡(jiǎn)介：

Cytokeratin 19 fragment (CY211) Recombinant Rabbit mAb (Alexa Fluor??488 Conjugate) (SDT-197-28)

產(chǎn)品型號(hào)：S0B1566

更新時(shí)間：2025-07-14

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：30

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

CDx 抗體 | 新興靶點(diǎn)B7-H3/H4，助力ADC藥物研發(fā)

斯達(dá)特特色產(chǎn)品推薦之：PD-1 功能性抗體

腫瘤靶點(diǎn)的“新寵”-Claudin18.2抗體現(xiàn)貨！

產(chǎn)品介紹

Cytokeratin 19 fragment （CYFRA 21-1） is a fragment of cytokeratin 19 that is typically associated with epithelial cell cancers, including NSCLC, and is typically associated with the SQLC type. Since cytokeratins are structural proteins of keratin-containing intermediate filaments found in the epithelial cells, their degradation produces soluble fragments which are measurable in the blood of lung cancer patients as a tumor marker. Other examples of cytokeratin fragments include tissue polypeptide antigen and tissue polypeptide-specific antigen. CYFRA 21-1 is known to be correlated with disease response and the prognosis of lung cancer but cannot be used to differentiate cancer patients from patients with respiratory diseases.

上一個(gè)：S0B1567ErbB2 Recombinant Rabbit mAb (Alexa Fluor??488 Conjugate) (SDT-069-57)